<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1152198</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Integration of transcriptomics, proteomics, and metabolomics data for the detection of the human pathogenic <italic>Prototheca wickerhamii</italic> from a One Health perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1063430"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Juan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2186497"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Teng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2126006"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Lei</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2266885"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jiang</surname>
<given-names>Cizhong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/129113"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wu</surname>
<given-names>Wenjuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/466083"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Laboratory Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Microscopy Core Facility, Biomedical Research Core Facilities, Westlake University</institution>, <addr-line>Hangzhou, Zhejiang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Victoriano Garre, University of Murcia, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Mariusz Dyl&#x105;g, University of Wroclaw, Poland; Qiangqiang Zhang, Fudan University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Cizhong Jiang, <email xlink:href="mailto:czjiang@tongji.edu.cn">czjiang@tongji.edu.cn</email>; Wenjuan Wu, <email xlink:href="mailto:wwj1210@126.com">wwj1210@126.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Fungal Pathogenesis, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1152198</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Guo, Chen, Li, Gao, Jiang and Wu</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Guo, Chen, Li, Gao, Jiang and Wu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Prototheca</italic> species are the only microalgae known to cause opportunistic infections in vertebrates and humans. Most cases of protothecosis in humans are caused by <italic>Prototheca wickerhamii</italic>, but knowledge of the pathogenicity and biology of <italic>Prototheca</italic> is limited. Globally, the diagnostic rate of <italic>Prototheca</italic> species infection is much lower than the actual rate of <italic>P. wickerhamii</italic>. The precise mechanisms underlying the pathogenesis of <italic>Prototheca</italic> infections remain unclear. In this study, we identified a strain of <italic>P. wickerhamii</italic> with atypical colony morphology. To reveal the morphological differences between <italic>P. wickerhamii</italic> S1 (mucous) and the molecular basis of its pathogenicity, the transcriptomics, proteomics, and metabolomics of two pathogenic <italic>P. wickerhamii</italic> strains and one environmental strain were analysed. Interestingly, mannan endo-1,4-&#x3b2;-mannosidase was significantly downregulated in <italic>P. wickerhamii</italic> S1, which contributes to a thinner cell wall in S1 compared to strains with typical colony morphology, and the toxicity of macrophages is reduced. Metabolite analysis revealed that the mucoid appearance of <italic>P. wickerhamii</italic> S1 may have been caused by an increase in linoleic acid, glycerol, and other metabolites. There is still a need to better understand the ecology, aetiology, and pathogenesis of <italic>P. wickerhamii</italic>, and in particular, its transmission between humans, animals, and the environment, from a One Health perspective.</p>
</abstract>
<kwd-group>
<kwd>prototheca</kwd>
<kwd>algae</kwd>
<kwd>protothecosis</kwd>
<kwd>metabolomics</kwd>
<kwd>transcriptomics</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="32"/>
<page-count count="9"/>
<word-count count="4585"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Fungal Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Wilhelm Kr&#xfc;ger, a German plant physiologist, first discovered the green algae <italic>Prototheca</italic> in 1894 (<xref ref-type="bibr" rid="B14">Kr&#xfc;ger, 1894</xref>). The first case of <italic>Prototheca</italic> infection in humans was described in a 31-year-old farmer in 1961 (<xref ref-type="bibr" rid="B23">Nelson et&#xa0;al., 1987</xref>). Considering that the colony morphology was similar to that of yeast-like fungi, <italic>Prototheca</italic> was initially identified as a fungus. Potential virulence factors involved in protothecosis have been identified using genomics, and many <italic>P. wickerhamii</italic> pathogenicity genes have been associated with fungi (<xref ref-type="bibr" rid="B1">Baku&#x142;a et&#xa0;al., 2021</xref>). However, the genus <italic>Prototheca</italic> has recently been classified into the family of the green algae Chlorellaceae. Of the 18 <italic>Prototheca</italic> species, only <italic>P. wickerhamii</italic>, <italic>P. blaschkeae</italic>, <italic>P. bovis</italic>, <italic>P. cutis</italic>, <italic>P. miyajii</italic>, and <italic>P. ciferrii</italic> have been implicated as vertebrate and human pathogens (<xref ref-type="bibr" rid="B12">Kano et&#xa0;al., 2022</xref>). <italic>P. bovis</italic> is the most virulent and causes most bovine mastitis cases. <italic>P. wickerhamii</italic> has rarely been described in milk from cows with mastitis; however, recently, <italic>P. wickerhamii</italic> was identified as a pathogenic <italic>Prototheca</italic> causative agent of bovine mastitis (<xref ref-type="bibr" rid="B20">Marques et&#xa0;al., 2006</xref>). <italic>P. wickerhamii</italic> can infect and survive in macrophages, resulting in persistent infection. The predominant <italic>Prototheca</italic> microalga isolated from cat protothecosis is <italic>P. wickerhamii</italic> (<xref ref-type="bibr" rid="B21">Masuda et&#xa0;al., 2021</xref>). In a three-year-old goat, protothecosis was caused by <italic>P. wickerhamii</italic> with a slowly progressive infection causing necrotising lesions and multifocal pyogranulomatous lesions on the skin of the face and head (<xref ref-type="bibr" rid="B3">Camboim et&#xa0;al., 2011</xref>). <italic>P. wickerhamii</italic> can cause underweight carp (<xref ref-type="bibr" rid="B5">Jagielski et&#xa0;al., 2017</xref>), and strains can be isolated from pigeons drinking wastewater (<xref ref-type="bibr" rid="B26">Rosario Medina et&#xa0;al., 2017</xref>). <italic>P. wickerhamii</italic> colonises flower bract water and fresh stumps (<xref ref-type="bibr" rid="B24">Pore, 1985</xref>) and was isolated, as the most abundant species, from raw sludge and sewage from wastewater treatment plants. <italic>P. wickerhamii</italic> can colonise the fingernails, skin, digestive system, and respiratory tract of humans. Furthermore, <italic>Prototheca</italic> microalgal infections may progress after contamination of wastewater and soil. (<xref ref-type="bibr" rid="B11">Kano, 2020</xref>).</p>
<p>For more knowledge of this fungal-like pathogen, the Medical Phycology (protothecosis and chlorellosis) Symposium was held during the 20<sup>th</sup> Congress of the International Society for Human and Animal Mycology (<xref ref-type="bibr" rid="B21">Masuda et&#xa0;al., 2021</xref>). The clinical forms of human protothecosis include cutaneous lesions, olecranon bursitis, and disseminated and systemic infections. More than 50% of the cases were skin infections, and other miscellaneous cases included wounds, nail lesions, olecranon bursitis, peritonitis, blood poisoning, and disseminated infections. With an improvement or cure rate of approximately 78%, skin infections have a first-class prognosis. Blood and disseminated infection cases have the worst prognosis, with a mortality rate of approximately 56% and 33% improvement or cure (<xref ref-type="bibr" rid="B28">Todd et&#xa0;al., 2018</xref>). Surgery was the most common cause of hospital-acquired infections. When skin injuries occur in patients colonised with predisposing factors, they may become infected after exposure to water contaminated with <italic>P. wickerhamii</italic>. Since the first human outbreak of <italic>Prototheca</italic> in 2018, it has become necessary to understand the ecology and pathogenesis in humans, environments, and animals from a One Health perspective (<xref ref-type="bibr" rid="B17">Libisch et&#xa0;al., 2022</xref>). As an increasing number of cases are reported worldwide, the impact of <italic>Prototheca</italic> infection on human and animal health is increasing. <italic>Prototheca</italic> has been isolated from natural water sources and artificial aquatic reservoirs (<xref ref-type="bibr" rid="B9">Jagielski et al., 2022</xref>). The primary source of <italic>Prototheca</italic> isolates is wastewater from cities, with <italic>P. wickerhamii</italic> being the most common isolate (<xref ref-type="bibr" rid="B25">Pore et&#xa0;al., 1983</xref>). In Poland, a study on the occurrence of <italic>Prototheca</italic> in freshwater ecosystems identified <italic>P. wickerhamii</italic> (17/51, 33%) as the most abundant <italic>Prototheca</italic> microalga, followed by <italic>P. pringsheimii</italic>, <italic>P. cerasi</italic>, <italic>P. bovis</italic>, <italic>P. ciferrii</italic>, <italic>P. cookei</italic>, and <italic>P. zopfii</italic>. <italic>P. wickerhamii</italic> is the major isolate collected from rivers and streams in the environment (<xref ref-type="bibr" rid="B6">Jagielski et&#xa0;al., 2022</xref>).</p>
<p>
<italic>Prototheca</italic> species have a two-layered cell wall (<xref ref-type="bibr" rid="B23">Nelson et&#xa0;al., 1987</xref>). The <italic>Prototheca</italic> cell wall is different from fungal and plant cell walls and does not contain chitin or cellulose. <italic>Prototheca</italic> has a thin outer layer and a thick inner layer. The release of <italic>P. wickerhamii</italic> endospores occurs every 5&#x2013;6 h with adequate nutrients (<xref ref-type="bibr" rid="B11">Kano, 2020</xref>). The size of <italic>P. wickerhamii</italic> sporangia is 3&#x2013;10 &#x3bc;m and is smaller than that of <italic>P. bovis</italic> and <italic>P. ciferrii</italic> (<xref ref-type="bibr" rid="B9">Jagielski et al., 2019a</xref>). <italic>Prototheca</italic> biofilms increase resistance to antimicrobial agents (<xref ref-type="bibr" rid="B27">Shave et al., 2021</xref>). It is necessary to apply a One Health perspective, which includes the environment, humans, and animals (<xref ref-type="bibr" rid="B10">Jinatham et&#xa0;al., 2021</xref>). To investigate the morphological differences and the molecular basis for the pathogenicity of different <italic>P. wickerhamii</italic> strains, we analysed transcriptomics, proteomics, and metabolomics data to determine the possible pathogenesis.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Sample preparation and collection</title>
<p>
<italic>P. wickerhamii</italic> S1 (mucous) was isolated from an 85-year-old female patient with a skin infection in Shanghai, China (<xref ref-type="bibr" rid="B4">Guo et&#xa0;al., 2022</xref>). <italic>P. wickerhamii</italic> HN01 (rough) was isolated from a 45-year-old male patient in Hunan, China, who had suffered from multiple skin infections and a bloodstream infection. <italic>P. wickerhamii</italic> ATCC 16529 was purchased from Thermo Fisher Scientific (Waltham, MA, USA). The strains were streak-inoculated onto Sabouraud dextrose agar (SDA) (Thermo Fisher Scientific) and incubated at 35&#xb0;C for 3&#x2013;5 days. Then, the colonies were harvested and washed with sterilised water (<xref ref-type="bibr" rid="B5">Jagielski et&#xa0;al., 2017</xref>). Primers used for PCR amplification and sequencing of the partial CYTB gene were cytb-F: GYGTWGAACAYATTATGAGAG-5&#x2019; and cytb-R: WACCCATAARAARTACCATTCWGG. Primers were used for both amplification and sequencing of degenerate nucleotides: Y, C, or T; R, A, or G; W, A, or T. The sequence of the CYTB gene of the strains in this study was aligned with the corresponding sequences retrieved from <italic>P. wickerhamii</italic> from the GenBank database.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Phenotypic characterization of <italic>P. wickerhamii</italic>
</title>
<p>Clinical strains S1 and HN01 of <italic>P. wickerhamii</italic> were subjected to micromorphological examination for phenotypic analysis. The morphological features of the cells were investigated on direct wet-mounted smears from SDA using an Olympus BX51 light and fluorescence microscope (Olympus Instruments Co., Tokyo, Japan). Images were taken using an Olympus U-TV0.63XC digital camera connected to a microscope. Olympus cellSens Standard 3.1 software was used for morphometric studies. <italic>P. wickerhamii</italic> cells were selected for fluorescence microscopy using the one-step fungal fluorescence staining method (Baso Diagnostic, Inc. Zhuhai, China).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Transmission electron microscopy</title>
<p>
<italic>P. wickerhamii</italic> S1 and HN01 were first picking into 20% BSA in cacodylate buffer (20 &#x3bc;L) and 0.8 &#x3bc;L BSA was transferred with a few samples to a 3 mm-diameter,100 &#x3bc;m-deep well of an aluminium carrier disk (Engineering Office of M. Wohlwend), quickly capped with a 0.16&#xa0;mm &#xd7; 3&#xa0;mm sapphire disc (flat side coated with hexadecene), loaded into a customised 0.66&#xa0;mm &#xd7; 3.05&#xa0;mm HPF specimen holder for rapid freezing at ~2,050 bar pressure for 340&#x2013;360 ms using a Leica ICE HPF machine, and kept in liquid nitrogen until use.</p>
<p>The specimens were treated with a cocktail of 1% osmium tetroxide, 0.2% uranyl acetate, 3% H<sub>2</sub>O in acetone, and 5% methanol at -90&#xb0;C for 72&#xa0;h. The temperature was raised to -60&#xb0;C for 15&#xa0;h and kept at -60&#xb0;C for 24&#xa0;h, then raised to -20&#xb0;C for 15&#xa0;h, and increased to 20&#xb0;C from 2 to 17&#xa0;h. This was followed by four washes with 100% acetone, each for 15&#xa0;min. Subsequently, the specimens were incubated with 1% thiocarbohydrazide in 80% methanol at room temperature (RT) for 60&#xa0;min, followed by six washes, each for 10&#xa0;min, with 100% acetone. The specimens were stained with 2% osmium tetroxide in acetone at RT for 1&#xa0;h and washed with 100% acetone four times each for 15&#xa0;min, followed by incubation in 0.5% uranyl acetate in acetone in the dark overnight at 4&#xb0;C. After four washes in pure acetone, each for 15&#xa0;min, the samples were incubated in Epon resin with pure acetone for 3&#xa0;h (at a ratio of 1:3), 3&#xa0;h (at a ratio of 1:2), 3&#xa0;h (at a ratio of 1:1), 3&#xa0;h (at a ratio of 3:1), and 6&#xa0;h each time, with four repetitions (100% Epon resin) on a rocker. The samples were embedded with freshly made resin and cured overnight at 38&#xb0;C and then polymerised in a 60&#xb0;C oven for 48&#xa0;h. For transmission electron microscopy (TEM), samples were sliced (approximately 70 nm thick) using a Leica EM UC7 ultramicrotome and collected on copper grids. Sections of spermatids collected by FACS were stained with 2% uranyl acetate and Sato&#x2019;s triple lead. All sections were imaged using a Talos L120C TEM (Thermo Fisher Scientific) at 80 kV, equipped with a 4 k &#xd7; 4 k Ceta CCD camera.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Scanning electron microscopy</title>
<p>The liquid cultures of <italic>P. wickerhamii</italic> S1 and HN01 were centrifuged at 10,000 rpm. The pellets were washed with 0.1 M sodium phosphate buffer (PB) pH 7.3 three times. The pellets were then fixed with 2.5% glutaraldehyde (25% glutaraldehyde ampules; Ted Pella Co., Redding, CA, USA) and 2% paraformaldehyde (16% paraformaldehyde; Ted Pella Co.) mixture in PB by incubating at RT for 30&#xa0;min, then incubating at 4&#xb0;C overnight. The pellet was washed three times with PB and collected by centrifugation. The samples were dehydrated using different ethanol volumes (30, 50, 70, 80, and 90%), and for each ethanol volume, incubated on ice for 10&#xa0;min. Samples were incubated in 100% ethanol at RT three times (total of 1&#xa0;h). The samples were dried using a critical-point dryer with a final rinse in pure ethanol. The dried samples were mounted on stubs containing carbon adhesives and a palladium coating of approximately 6 nm. For scanning electron microscopy (SEM), the samples were placed in a Zeiss Gemini Smart FE-SEM 550 (Zeiss, Germany) and imaged at 1.5 Kv and 4 k &#xd7; 4 k.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Transcriptome data analysis</title>
<p>Nine samples (three <italic>P. wickerhamii</italic> strains ATCC16529, S1, and HN01, each with three biological replicates) were included in this study. The RNA-seq raw reads were preprocessed using SOAPnuke v1.4.0 (<xref ref-type="bibr" rid="B32">Yuxin et&#xa0;al., 2018</xref>). The clean reads were then mapped to the reference gene sequence (Bowtie 2 v2.2.5) (<xref ref-type="bibr" rid="B2">Ben and Salzberg, 2012</xref>) to acquire the position information and unique read features of the nine sequenced samples. The gene expression levels of individual samples were then calculated as fragments per kilobase per million mapped reads (FPKM) using RSEM v1.2.8 (<xref ref-type="bibr" rid="B16">Li and Dewey, 2011</xref>). Significantly differentially expressed genes (DEGs) between the two <italic>P. wickerhamii</italic> strains were identified using DEseq 2 (fold change &gt; 2 and P &lt; 0.05) (<xref ref-type="bibr" rid="B19">Love et al., 2014</xref>).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Proteome data analysis</title>
<p>The MSstats R package (<xref ref-type="bibr" rid="B22">Meena et&#xa0;al., 2014</xref>) was used to quantify the peptides and proteins from the mass spectrometry data of the 12 samples (three <italic>P. wickerhamii</italic> strains, each with four biological replicates). The MSstats R package was also used for intrasystem error correction and normalisation for each sample. Significantly differentially expressed proteins (DEPs) between the two types of <italic>P. wickerhamii</italic> strains were identified with a fold change &gt; 2 and P &lt; 0.05. For the functional annotation of a protein set, the protein sequences were aligned to Eukaryotic Orthologous Groups (KOG) using BLASTp with an E-value of 1E&#x2212;5 or less (<xref ref-type="bibr" rid="B13">Koonin et&#xa0;al., 2004</xref>).</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Metabolome data analysis</title>
<p>The 18 sample result files (three <italic>P. wickerhamii</italic> strains, each with six biological replicates) from Compound Discoverer were input into MetaX for data preprocessing and further analysis. After the log 2 transformation of the data, a PLS-DA model was established to screen the differential metabolites between two types of <italic>P. wickerhamii</italic> strains, with the scaling method Pareto and a 7-fold cross-validation. Significantly differential metabolites were defined as fold change &gt; 2, P-value &lt; 0.05, and variable importance for projection (VIP) &gt;1. Pathway enrichment analysis of significantly differentially expressed metabolites was performed using the Kyoto Encyclopedia of Genes and Genomes pathway database (<uri xlink:href="https://www.kegg.jp/kegg/pathway.html">https://www.kegg.jp/kegg/pathway.html</uri>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Macrophage cytotoxicity assay</title>
<p>Exponentially growing cells of the three <italic>P. wickerhamii</italic> strains were cocultured with bone marrow-derived macrophages (BMDMs) (multiplicity of infection [MOI]&#x2009;=&#x2009;1:1) at 37&#xb0;C with 5% CO<sub>2</sub> for 6 and 24&#x2009;h, respectively. After incubation, the cells were fixed with 4% formaldehyde, washed, stained with calcofluor white (10&#xa0;min co-incubation), and observed under a fluorescence microscope. The concentration of lactose dehydrogenase (LDH) was assayed to determine the cytotoxicity of the three <italic>P. wickerhamii</italic> strains (CytoTox 96 Non-Radioactive Cytotoxicity Assay; Promega, Madison, WI, USA). Released LDH in culture supernatants was measured for 30&#xa0;min, coupled with an enzymatic assay, which was used to measure the membrane integrity for cell-mediated cytotoxicity assays to measure the lysis of target cells by the three <italic>P. wickerhamii</italic> strains.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Statistical analysis</title>
<p>Statistical tests were performed using the Student&#x2019;s t-test and Wilcoxon test. Statistical significance was set at P &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Description of <italic>P. wickerhamii</italic> strains HN01 and S1</title>
<p>
<italic>P. wickerhamii</italic> HN01 colony morphology was consistent with that of ATCC16529; sporangia and sporangiospores were globose, and the capsule was absent. The diameter of <italic>P. wickerhamii</italic> HN01 sporangia measured 2.69&#x2013;5.90&#x2009;&#x3bc;m. After incubation on SDA at 35&#xb0;C for 3 days, the colonies were creamy white, raised, and circular, with a smooth surface and a diameter of 3&#x2013;5 mm (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). <italic>P. wickerhamii</italic> HN01 can grow at 28 or 37&#xb0;C.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Phenotypic characterization of <italic>P. wickerhamii</italic> HN01 (rough) and S1 (mucous) <bold>(A)</bold> Colonies on Sabouraud dextrose agar for 3 days at 35&#xb0;C. <bold>(B)</bold> Details of cell morphology, as seen using optical microscopy (fluorescence stain, &#xd7;1,000). <bold>(C)</bold> TEM and <bold>(D)</bold> SEM (&#xd7;6,000).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1152198-g001.tif"/>
</fig>
<p>
<italic>P. wickerhamii</italic> S1 sporangia were globose to ellipsoidal or angular, sporangiospores were globose to angular and water drop-shaped, and the capsule was absent. The diameter size of <italic>P. wickerhamii</italic> S1 sporangia on average was 1.53-3.65&#x2009;&#x3bc;m. After incubation on SDA at 35&#xb0;C for 3 days, colonies were creamy white, glistening, circular, raised, and slimy, with a smooth surface and margins, and were up to 3&#x2013;5&#x2009;mm in diameter (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). <italic>P. wickerhamii</italic> S1 grew well at 28 and 37&#xb0;C. The cell wall thickness of the HN01 and S1 strains were 0.14 and 0.05 &#x3bc;m, respectively.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Bioinformatics analysis and interpretation of morphological differences between <italic>P. wickerhamii</italic> strains HN01 and S1</title>
<p>To better understand the differences at the macro- and micromorphological levels between the two <italic>P. wickerhamii</italic> strains S1 and HN01, we studied their transcriptome, proteome, and metabolome data for comparison. These data were highly reproducible (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1</bold>
</xref>). The results showed that the number of DEGs between <italic>P. wickerhamii</italic> strains S1 and ATCC16529 was much higher than that between HN01 and ATCC16529. This was also true for the DEPs and metabolites (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). This is consistent with previous results showing that strains HN01 and ATCC16529 evolved closely (<xref ref-type="bibr" rid="B4">Guo et&#xa0;al., 2022</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Multi-omics profiles of three <italic>P. wickerhamii</italic> strains ATCC16529, S1 (mucous), and HN01 (rough). <bold>(A)</bold> Venn diagram showing overlap of differentially expressed genes (left), proteins (middle), and metabolites (right) between <italic>P. wickerhamii</italic> strains ATCC and S1/HN01. Numbers indicate the count of differentially expressed genes, proteins, and metabolites. <bold>(B)</bold> Expression levels of mannan endo-1,4-&#x3b2;-mannosidase in <italic>P. wickerhamii</italic> strains HN01 and S1. (Student&#x2019;s t-test). <bold>(C)</bold> Functional annotation of significantly down-regulated proteins in S1 compared to HN01. <bold>(D)</bold> Differentially expressed metabolites between strains HN01 and S1. <bold>(E)</bold> Enriched pathways of significantly upregulated metabolites in strain S1 compared to HN01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1152198-g002.tif"/>
</fig>
<p>Interestingly, we found that mannan endo-1,4-&#x3b2;-mannosidase was significantly downregulated in S1 compared to that in HN01 (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). This produced less glucan and mannan, which are the two main components of the algal cell wall. Consequently, this contributed to a thinner cell wall in the mucous strain compared to that in isolate S1 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>).</p>
<p>Next, we performed a functional annotation of the significantly downregulated proteins in <italic>P. wickerhamii</italic> S1. Strikingly, the results showed that they were enriched in cell wall-related functions such as cell wall/membrane/envelope biogenesis, extracellular structures, collagens (type IV and XIII), and related proteins such as GDP-mannose pyrophosphorylase/mannose-1-phosphate guanylyltransferase (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). These results are consistent with the transcriptome results, further suggesting that the downregulation of mannose-related enzymes may be responsible for the thin cell wall in S1.</p>
<p>The mucoid appearance of the S1 strain was likely due to the secretion of abnormal metabolites. Therefore, we identified differential metabolites between S1 and HN01, including significantly increased glycerol-related metabolites in S1 such as glycerol 2-phosphate, glycerol 3-phosphate, 2-linoleoyl glycerol, etc. (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). This may partially explain the mucoid appearance of S1.</p>
<p>We further analysed the pathways in cases in which metabolites were significantly upregulated in S1 compared to HN01. The results showed that they were enriched in glycerol-related pathways, such as linoleic acid metabolism, fatty acid metabolism, and arachidonic acid metabolism (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). Taken together, we speculate that the mucoid appearance of S1 may be caused by an increase in linoleic acid, glycerol, and other metabolites.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Cytotoxicity of <italic>P. wickerhamii</italic> S1 strain to macrophages is significantly lower than that of HN01</title>
<p>To compare the differences between the two strains with different morphologies in inducing host immune cell responses, we investigated the interaction of <italic>P. wickerhamii</italic> and macrophages co-cultured <italic>P. wickerhamii</italic> strains with macrophages. RAW264.7 macrophages were co-cultured with <italic>P. wickerhamii</italic> at a ratio of 1:1 (MOI = 1) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Compared to the LDH of <italic>P. wickerhamii</italic> in a medium without macrophages, we found that the macrophage cytotoxicity of isolate HN01 was 14.52% at 24&#xa0;h, but S1 showed lower viability (1.87%) compared to HN01. However, the cytotoxic effects of <italic>P. wickerhamii</italic> ATCC16529 were 9.91%. These results show that S1 caused much less damage to macrophages than strains HN01 and ATCC16529.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Cytotoxicity of ATCC16529, S1 (mucous) and HN01 (rough) strains to bone marrow-derived macrophages. <bold>(A)</bold> Three <italic>P. wickerhamii</italic> strains and bone marrow-derived macrophages (BMDMs) were co-cultured and stained with calcofluor white, <bold>(B)</bold> Three <italic>P. wickerhamii</italic> strains showed different macrophage cytotoxicity (%).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1152198-g003.tif"/>
</fig>
<p>Thus, <italic>P. wickerhamii</italic> S1 showed lower cytotoxicity against macrophages, which could help <italic>P. wickerhamii</italic> escape macrophage clearance. Furthermore, the mechanisms underlying the innate immune response against <italic>P. wickerhamii</italic> should be elucidated in future studies. Taken together, S1 caused less macrophage death than HN01 and ATCC16529 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), which may be related to the abnormal thinning of the S1 cell wall.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Strain isolation of <italic>P. wickerhamii</italic> in China based on One Health</title>
<p>In China, we collected 31&#xa0;<italic>P. wickerhamii</italic> strains that cause human infections, mainly from 15 provinces and cities (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). These cases were mainly concentrated in provinces and cities in southern China with developed waters, including domestic sewage and artificial watercourses. Shanghai, Fujian, Jiangxi, Zhejiang, and Guangxi had the highest separation rates of <italic>P. wickerhamii</italic> strains at 16.13% (5/31), 12.90% (4/31), 12.90% (4/31), 12.90% (4/31), and 9.68% (3/31), respectively. There have also been cases of <italic>P. wickerhamii</italic> bloodstream infections that have led to death, although most cases involved multiple skin infections. In China, owing to the lack of understanding of the pathogenicity and biology of <italic>P. wickerhamii</italic>, the correct diagnosis rate of <italic>P. wickerhamii</italic> infections is very low. For example, no cases of infection were found in the Hubei and Guizhou provinces.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Thirty-one <italic>P. wickerhamii</italic> strains from 15 provinces and cities in China.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1152198-g004.tif"/>
</fig>
<p>According to the literature, <italic>P. wickerhamii</italic> infections have also been reported in Hong Kong and Taiwan. Unfortunately, there are no studies involving a large-scale investigation of <italic>P. wickerhamii</italic> contamination in both natural and artificial waterbodies in China. However, many reports have shown that <italic>P. wickerhamii</italic> is widespread in the environment and can cause infections in animals. With further research, new species and atypical strains of <italic>Prototheca</italic> may be found in the environment and in animal or human infections.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>
<italic>Prototheca</italic> are non-photosynthetic, unicellular microalgae associated with severe infections (<xref ref-type="bibr" rid="B23">Nelson et&#xa0;al., 1987</xref>). <italic>Prototheca</italic> are the only microalgae which have been reported to infect animals and humans, causing many forms of <italic>Prototheca</italic> infection (<xref ref-type="bibr" rid="B9">Jagielski et al., 2019b</xref>). Standard treatment guidelines for protothecosis have not yet been established in humans worldwide (<xref ref-type="bibr" rid="B31">Yamashita et&#xa0;al., 2022</xref>). Microalgae often exhibit high levels of resistance to many antimicrobial agents, and there is a low correlation between <italic>in vitro</italic> susceptibility and clinical responses (<xref ref-type="bibr" rid="B15">Lass-Fl&#xf6;rl and Mayr, 2007</xref>). The <italic>P. wickerhamii</italic> genome encodes several virulence factors, including those identified in <italic>Candida albicans</italic> and <italic>Trichophyton rubrum</italic>. These virulence factors are involved in host invasion and elicitation of the adaptive stress response. The ATPase and malate dehydrogenase genes encode proteins that are potential virulence factors in <italic>Prototheca</italic> (<xref ref-type="bibr" rid="B1">Baku&#x142;a et&#xa0;al., 2021</xref>).</p>
<p>Culture-based studies can be used to screen for <italic>Prototheca</italic> microalgal isolates from the environment. <italic>P. wickerhamii</italic> has been isolated from food and drinking water; therefore, we need to understand the ecology and pathogenesis of <italic>P. wickerhamii</italic> in different humans, environments, and animals using a One Health approach. With the effects of global climate change, the medium to pathogenic potential of <italic>P. wickerhamii</italic> should be considered from a One Health perspective. The most frequently isolated <italic>Prototheca</italic> species were <italic>P. wickerhamii</italic> (33%), <italic>P. pringsheimii</italic> (23%), and <italic>P. cerasi</italic> (14%) in Poland. Moreover, higher temperatures combined with high humidity would enhance the growth of <italic>P. wickerhamii</italic> in the environment (<xref ref-type="bibr" rid="B6">Jagielski et&#xa0;al., 2022</xref>). This study provides an in-depth understanding of the genome sequences of different strains of <italic>P. wickerhamii</italic> isolated from clinical specimens, contributes to a basic understanding of this alga, and explores future prevention and treatment strategies (<xref ref-type="bibr" rid="B4">Guo et&#xa0;al., 2022</xref>).</p>
<p>Multiomics analysis and molecular typing of strains isolated from the environment, together with those causing infections, could shed light on the aetiology of <italic>P. wickerhamii</italic> infections. The treatment of human skin and systemic infections by <italic>Prototheca</italic> includes antifungal agents such as azoles. <italic>Prototheca</italic> shares similar features with yeast-like fungi, specifically the presence of ergosterol in the cell membrane, which is approximately three times lower than that in fungal membranes (~4% vs. ~12%). Intravenous amphotericin B is the most effective treatment for <italic>P. wickerhamii</italic> infections. Fluconazole and itraconazole showed cure and improvement rates of 65% and 71%, respectively. Oral itraconazole or fluconazole was recommended for relatively mild cases, and intravenous amphotericin B was used to treat serious infections that azole treatment failed to treat (<xref ref-type="bibr" rid="B28">Todd et&#xa0;al., 2018</xref>). <italic>In vitro</italic> tests have confirmed that ravuconazole is more effective than other azoles in treating <italic>P. wickerhamii</italic> infections (<xref ref-type="bibr" rid="B30">Watanabe et&#xa0;al., 2021</xref>). The echinocandins are generally ineffective because polysaccharides in the <italic>P. wickerhamii</italic> cell wall are typically &#x3b2;-1, 4-bonded. The development of more effective drugs is required for the treatment of animal and human protothecosis (<xref ref-type="bibr" rid="B11">Kano, 2020</xref>). <italic>In vitro</italic> studies have shown that silver nanoparticles are novel algicidal agents (<xref ref-type="bibr" rid="B8">Jagielski et al., 2018</xref>).</p>
<p>Studies have shown that MoTup1 is necessary for fungal pathogen virulence. CaTUP1 and Tup1 are related to transcription factors and inhibitors, respectively. Therefore, transcriptional regulation may be important in the pathogenesis of human protothecosis (<xref ref-type="bibr" rid="B4">Guo et&#xa0;al., 2022</xref>). Of the 245 proteins identified in <italic>Prototheca zopfii</italic> from the iTRAQ-LC-MS/MS proteomic analysis, only 22 proteins were clearly identified, most of which were putative uncharacterised proteins (<xref ref-type="bibr" rid="B18">Liu et&#xa0;al., 2018</xref>). This study identified the reason for the mucoid appearance of the S1 strain, which was more likely due to the mucous secretion of abnormal metabolites, such as glycerol 2-phosphate, glycerol 3-phosphate, and 2-linoleoyl glycerol.</p>
<p>Expanding knowledge based on genome sequencing (<xref ref-type="bibr" rid="B1">Baku&#x142;a et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B4">Guo et&#xa0;al., 2022</xref>) and transcriptomic, proteomic, and metabolomic analyses of <italic>P. wickerhamii</italic> may contribute to a better understanding of the pathways of infection and pathogenesis. The <italic>Prototheca</italic> cell wall is a complex structure composed primarily of &#x3b2;-glucan and mannan. Pathogenic <italic>Prototheca</italic> can expose specific pathogen molecular patterns at their cell surface, which can be recognised by human or animal pattern recognition receptors, potently stimulating the immune response. <italic>Prototheca</italic> should be able to alter the cell wall architecture, enabling them to escape the immune system. Glycoside hydrolases cleave glycosidic bonds between polysaccharides and oligosaccharides and are important virulence factors in many fungal species. ROT2 and SKN1 in <italic>C. albicans</italic> have been linked to cell wall synthesis, and mutants of these genes show decreased <italic>in vitro</italic> virulence (<xref ref-type="bibr" rid="B1">Baku&#x142;a et&#xa0;al., 2021</xref>). In the present study, we examined the macrophage cytotoxicity of strains S1, HN01, and ATCC16529, which supported the importance of intact cell walls in the induction of immune responses. These results prompted us to closely examine the structural complexity of <italic>P. wickerhamii</italic> cell walls (<xref ref-type="bibr" rid="B29">Wang et&#xa0;al., 2022</xref>).</p>
<p>This study has some limitations. <italic>P. wickerhamii</italic> genotypes exhibited growth differences when cultured at different temperatures. Considering the limited data on the pathogenicity of <italic>P. wickerhamii</italic> and that many proteins in the protosheath genome are still annotated as hypothetical proteins, it is reasonable to identify a relatively high proportion of functionally unknown proteins (<xref ref-type="bibr" rid="B18">Liu et&#xa0;al., 2018</xref>). The environmental isolate ATCC16529 at 35&#xb0;C may have induced the expression of stress-related proteins. However, environmental <italic>Prototheca</italic> species have been known to colonise the human skin and other parts or systems, and growth is optimised between 25&#xb0;C and 37&#xb0;C. Our study aims to compare the phenotypic characteristics of <italic>P. wickerhamii</italic> clinical strains S1 and HN01. Comparing the differences between these two strains with different morphologies in terms of macrophage cytotoxicity, we found that S1 was significantly less cytotoxic than HN01. The proteomics results were consistent with the transcriptome results, further suggesting that the downregulation of mannose-related enzymes may indeed be responsible for the thin cell wall in S1. Mannan endo-1,4-&#x3b2;-mannosidase may be linked to cell wall synthesis and shows decreased virulence in <italic>P. wickerhamii in vitro</italic>. From a One Health perspective, we will gain a deeper understanding of the ecology, aetiology, pathogenesis, and transmission routes of <italic>P. wickerhamii</italic> between different hosts, environments, and habitats.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>In this study, we show for the first time the phenotypic characterisation of different pathogenic isolates of <italic>P. wickerhamii</italic> clinical strains S1 and HN01. Our data provide evidence of differences in protein expression between these two isolates. The results indicate that S1 differs from HN01 in terms of cell wall thickness, composition, and macrophage cytotoxicity. Further transcriptomic, proteomic, and metabolomic studies will provide valuable information on the pathogenic mechanisms of <italic>P. wickerhamii</italic> infection. Future studies investigating mannan endo-1,4-&#x3b2;-mannosidase and cell wall function-related proteins are needed, such as cell wall/membrane/envelope biogenesis, extracellular structures, collagens (type IV and XIII) and related proteins, and GDP-mannose pyrophosphorylase/mannose-1-phosphate guanylyltransferase.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the ethics committee of Shanghai East Hospital, Tongji University School of Medicine (No. 2020-163).</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>Conceptualisation: JG, JC and TL. Formal analysis: JG and JC. Funding acquisition: WW and CJ. Methodology: JG, JC, TL, LG, WW and CJ. Supervision: WW and CJ. Writing the original draft: JG and JC. Writing, review, and editing: WW and CJ. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (Grant Nos. 81971990, 82172326, and 8190080864), Excellent Technology Leader in Shanghai (grant number 20XD1434500).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank the Beijing Genomics Institute (BGI) Co., LTD for their technical support.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1152198/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1152198/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baku&#x142;a</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Siedlecki</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gromadka</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gawor</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gromadka</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pomorski</surname> <given-names>J. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A first insight into the genome of prototheca wickerhamii, a major causative agent of human protothecosis</article-title>. <source>BMC Genomics</source> <volume>22</volume> (<issue>1</issue>), <fpage>168</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12864-021-07491-8</pub-id>. <uri xlink:href="https://ncbi.nlm.nih.gov/?term=Panagiotopoulou+H&amp;cauthor_id=33750287">Panagiotopoulou</uri>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Salzberg</surname> <given-names>S. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Fast gapped-read alignment with bowtie 2</article-title>. <source>Nat. Methods</source> <volume>9</volume> (<issue>4</issue>), <page-range>357&#x2013;359</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camboim</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Garino</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Dantas</surname> <given-names>A. F.</given-names>
</name>
<name>
<surname>Sim&#xf5;es</surname> <given-names>S. V.</given-names>
</name>
<name>
<surname>Melo</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Azevedo</surname> <given-names>E. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Protothecosis by prototheca wickerhamii in goats</article-title>. <source>Mycoses</source> <volume>54</volume> (<issue>4</issue>), <fpage>e196</fpage>&#x2013;<lpage>e200</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1439-0507.2010.01864.x</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jian</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Genome sequences of two strains of prototheca wickerhamii provide insight into the protothecosis evolution</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.797017</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagielski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dyl&#x105;g</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Roesler</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Murugaiyan</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Isolation of infectious microalga prototheca wickerhamii from a carp (Cyprinus carpio) - a first confirmed case report of protothecosis in a fish</article-title>. <source>J. Fish Dis.</source> <volume>40</volume> (<issue>10</issue>), <fpage>1417</fpage>&#x2013;<lpage>1421</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jfd.12614</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagielski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Iskra</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Baku&#x142;a</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Rudna</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Roeske</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Nowakowska</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Occurrence of prototheca microalgae in aquatic ecosystems with a description of three new species, prototheca fontanea, prototheca lentecrescens, and prototheca vistulensis</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>88</volume> (<issue>22</issue>), <elocation-id>e0109222</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.01092-22</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagielski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Krukowski</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Bochniarz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Piech</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Roeske</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Baku&#x142;a</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>a). <article-title>Prevalence of prototheca spp. on dairy farms in Poland - a cross-country study</article-title>. <source>Microb. Biotechnol.</source> <volume>12</volume> (<issue>3</issue>), <fpage>556</fpage>&#x2013;<lpage>566</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1751-7915.13394</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagielski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nied&#x17a;wiecka</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Roeske</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Dyl&#x105;g</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>3-bromopyruvate as an alternative option for the treatment of protothecosis</article-title>. <source>Front. Pharmacol 9</source> <volume>375</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2018.00375</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagielski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Roeske</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Baku&#x142;a</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Piech</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Wlaz&#x142;o</surname> <given-names>&#x141;.</given-names>
</name>
<name>
<surname>Bochniarz</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>b). <article-title>A survey on the incidence of prototheca mastitis in dairy herds in lublin province, Poland</article-title>. <source>J. Dairy Sci.</source> <volume>102</volume> (<issue>1</issue>), <fpage>619</fpage>&#x2013;<lpage>628</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3168/jds.2018-15495</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jinatham</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Cantoni</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>I. R.</given-names>
</name>
<name>
<surname>Vichaslip</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Suwannahitatorn</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Popluechai</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Prototheca bovis, a unicellular achlorophyllous trebouxiophyte green alga in the healthy human intestine</article-title>. <source>J. Med. Microbiol.</source> <volume>70</volume> (<issue>9</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jmm.0.001415</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kano</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Emergence of fungal-like organisms: prototheca</article-title>. <source>Mycopathologia</source> <volume>185</volume> (<issue>5</issue>), <fpage>747</fpage>&#x2013;<lpage>754</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11046-019-00365-4</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kano</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kazuo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yaguchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Masuda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Makimura</surname> <given-names>K.</given-names>
</name>
<name>
<surname>de Hoog</surname> <given-names>G. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Phenotypic characteristics of prototheca species occurring in humans and animals</article-title>. <source>Med. Mycol J.</source> <volume>63</volume> (<issue>1</issue>), <fpage>17</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3314/mmj.21-00018</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koonin</surname> <given-names>E. V.</given-names>
</name>
<name>
<surname>Fedorova</surname> <given-names>N. D.</given-names>
</name>
<name>
<surname>Jackson</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Krylov</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Makarova</surname> <given-names>K. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>A comprehensive evolutionary classification of proteins encoded in complete eukaryotic genomes</article-title>. <source>Genome Biol.</source> <volume>5</volume> (<issue>2</issue>), <fpage>R7</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/gb-2004-5-2-r7</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kr&#xfc;ger</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>1894</year>). <article-title>Kurze Charakteristik einiger niedrerer Organismen im Saftfluss der Laubb&#xe4;ume</article-title>. <source>Hedwigia</source> <volume>33</volume>, <fpage>241</fpage>&#x2013;<lpage>266</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/cmr.00032-06</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lass-Fl&#xf6;rl</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mayr</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Human protothecosis</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>20</volume> (<issue>2</issue>), <fpage>230</fpage>&#x2013;<lpage>242</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/cmr.00032-06</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dewey</surname> <given-names>C. N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome</article-title>. <source>BMC Bioinf.</source> <volume>12</volume>, <elocation-id>323</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2105-12-323</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libisch</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Picot</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ceballos-Garzon</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Moravkova</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Klimesov&#xe1;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Telkes</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Prototheca infections and ecology from a one health perspective</article-title>. <source>Microorganisms</source> <volume>10</volume> (<issue>5</issue>), <elocation-id>938</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms10050938</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y. Z.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Kudinha</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>F. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Isobaric tag for relative and absolute quantitation-based comparative proteomic analysis of human pathogenic prototheca zopfii genotype 2 and environmental genotype 1 strains</article-title>. <source>J. Microbiol. Immunol. Infect.</source> <volume>51</volume> (<issue>3</issue>), <fpage>302</fpage>&#x2013;<lpage>311</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmii.2016.07.003</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Huber</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Anders</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol.</source> <volume>15</volume> (<issue>12</issue>), <elocation-id>550</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Carvalheira</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Short communication: <italic>In vitro</italic> antimicrobial susceptibility of prototheca wickerhamii and prototheca zopfii isolated from bovine mastitis</article-title>. <source>J. Dairy Sci.</source> <volume>89</volume> (<issue>11</issue>), <fpage>4202</fpage>&#x2013;<lpage>4204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3168/jds.S0022-0302(06)72465-1</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masuda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Jagielski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Danesi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Falcaro</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Bertola</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Krockenberger</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Protothecosis in dogs and cats-new research directions</article-title>. <source>Mycopathologia</source> <volume>186</volume> (<issue>1</issue>), <fpage>143</fpage>&#x2013;<lpage>152</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11046-020-00508-y</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meena</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ching-Yun</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Timothy</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Daniel</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Trevor</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Brendan</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>MSstats: an r package for statistical analysis of quantitative mass spectrometry-based proteomic experiments</article-title>. <source>Bioinf. (Oxford England)</source> <volume>30</volume> (<issue>17</issue>), <fpage>2524</fpage>&#x2013;<lpage>2526</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btu305</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Neafie</surname> <given-names>R. C.</given-names>
</name>
<name>
<surname>Connor</surname> <given-names>D. H.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Cutaneous protothecosis and chlorellosis, extraordinary "aquatic-borne" algal infections</article-title>. <source>Clin. Dermatol.</source> <volume>5</volume> (<issue>3</issue>), <fpage>76</fpage>&#x2013;<lpage>87</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0738-081x(87)80012-3</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pore</surname> <given-names>R. S.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Prototheca associated with banana</article-title>. <source>Mycopathologia</source> <volume>90</volume> (<issue>3</issue>), <fpage>187</fpage>&#x2013;<lpage>189</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/bf00436736</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pore</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Barnett</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Barnes</surname> <given-names>W. C.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Walker</surname> <given-names>J. D.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Prototheca ecology</article-title>. <source>Mycopathologia</source> <volume>81</volume> (<issue>1</issue>), <fpage>49</fpage>&#x2013;<lpage>62</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/bf00443909</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosario Medina</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Rom&#xe1;n Fuentes</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Batista Arteaga</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Real Valc&#xe1;rcel</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Acosta Arbelo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Padilla Del Castillo</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Pigeons and their droppings as reservoirs of candida and other zoonotic yeasts</article-title>. <source>Rev. Iberoam Micol</source> <volume>34</volume> (<issue>4</issue>), <fpage>211</fpage>&#x2013;<lpage>214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.riam.2017.03.001</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shave</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>Millyard</surname> <given-names>L.</given-names>
</name>
<name>
<surname>May</surname> <given-names>R. C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Now for something completely different: prototheca, pathogenic algae</article-title>. <source>PloS Pathog.</source> <volume>17</volume> (<issue>4</issue>), <elocation-id>e1009362</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1009362</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todd</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Matsumoto</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ueno</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Murugaiyan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Britten</surname> <given-names>A.</given-names>
</name>
<name>
<surname>King</surname> <given-names>J. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Medical phycology 2017</article-title>. <source>Med. Mycol</source> <volume>56</volume> (<supplement>suppl_1</supplement>), <fpage>S188</fpage>&#x2013;<lpage>s204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/mmy/myx162</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Innate immune responses against the fungal pathogen candida auris</article-title>. <source>Nat. Commun.</source> <volume>13</volume> (<issue>1</issue>), <fpage>3553</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-022-31201-x</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hirose</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nonaka</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Matsumura</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Characterization of prototheca CYP51/ERG11 as a possible target for therapeutic drugs</article-title>. <source>Med. Mycol</source> <volume>59</volume> (<issue>9</issue>), <fpage>855</fpage>&#x2013;<lpage>863</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/mmy/myab012</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashita</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ikeda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Ohama</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ando</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ikemura</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Protothecosis in the mucosa of the pharynx mimicking pharyngeal cancer in an immunocompetent individual: a case report</article-title>. <source>Ann. Clin. Microbiol. Antimicrob.</source> <volume>21</volume> (<issue>1</issue>), <elocation-id>5</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12941-022-00495-6</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuxin</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data</article-title>. <source>GigaScience</source> <volume>7</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gigascience/gix120</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>